Skip to main content
. Author manuscript; available in PMC: 2016 Jun 1.
Published in final edited form as: Ann Surg. 2015 Jun;261(6):1114–1123. doi: 10.1097/SLA.0000000000000971

Table 9. Length of Total Hospital Stay (LOS).

Variables N Univariable linear regression Multivariable linear regression

95% CI for β 95% CI for β


β Lower Upper P-Value β Lower Upper P-Value
Group
 A* 322
 B 386 -6.37 -8.29 -4.45 <0.001 -6.42 -8.29 -4.54 <0.001
Gender
 Male* 617
 Female 91 1.98 -0.96 4.92 0.186
Age Preoperative treatment 708 0.11 0.01 0.20 0.028
 No* 140
 Yes 568 -2.028 -4.50 -0.44 0.107
Diabetes
 No* 597
 Yes 111 -0.03 -2.74 2.67 0.980
COPD
 No* 663
 Yes 45 2.70 -1.33 6.73 0.189
CAD
 No* 589
 Yes 119 1.72 -0.92 4.35 0.201
Histology
 Adenocarcinoma* 643
 Squamous cell carcinoma 65 8.53 5.18 11.88 <0.001 5.87 1.92 9.81 0.004
Tumor location
 Upper/cervical/middle* 63
 Lower/GEJ 645 -8.47 -11.87 -5.07 <0.001 -5.04 -9.04 -1.04 0.014
Type of esophagectomy 0.001
 Ivor Lewis* 462
 Transhiatal 59 1.92 -1.67 5.50 0.294
 Total 49 7.84 3.95 11.73 <0.001
 Minimal invasive 124 -1.49 -4.10 1.14 0.267
 N/A 14 0.55 -6.48 7.58 0.877
Minimal invasive surgery
 No* 584
 Yes 124 -2.35 -4.93 0.24 0.075
Pathological stage
 0* 145
 I 149 -1.50 -4.56 4.56 0.337
 II 254 -0.92 -3.65 1.81 0.509
 III 144 -0.71 -3.79 2.38 0.654
 IV 16 1.62 -5.30 8.52 0.647
Clinical stage
 0* 5
 I 108 4.99 -7.00 16.97 0.414
 II 253 3.60 -8.23 15.44 0.550
 III 314 5.22 -6.60 17.03 0.386
 IV 28 4.94 -7.78 17.67 0.446
ASA-risk scale
 1-2* 122
 3-4 586 1.293 -1.31 3.90 0.330
Salvage operation
 No* 612
 Yes 96 2.87 0.002 5.74 0.050
*

Reference group.

Statistically significant for univariable analysis (p<0.25).

βindicates odds ratio; CI, confidence interval; COPD, chronic pulmonary obstructive disease; CA, coronary artery disease; GEJ, gastroesophageal junction; ASA, American Society of Anesthesiologist.